{"first_name":"Michael","last_name":"Kauffman","permalink":"michael-kauffman-2","crunchbase_url":"http://www.crunchbase.com/person/michael-kauffman-2","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Jan 17 07:31:23 UTC 2011","updated_at":"Mon Jan 17 07:34:21 UTC 2011","overview":"<p>Michael Kauffman was a cofounder of Karyopharm since the inception of the Company. Prior to joining Karyopharm, he was the chief medical officer of Onyx Pharmaceuticals Inc., which acquired Proteolix Inc., where he lead the development of carfilzomib, a novel proteasome inhibitor expected to be submitted for accelerated approval in refractory myeloma by Onyx as early as mid-2011. Dr. Kauffman was President and Chief Executive Officer of EPIX Pharmaceuticals, Inc. (previously Predix Pharmaceuticals, Inc.) from 2002 to 2008. He was the leader of the VelcadeÂ® Development Program at Millennium Pharmaceuticals, and held a number of senior positions at Millennium Predictive Medicine and Biogen. Dr. Kauffman received his M.D. and Ph.D. from Johns Hopkins Medical School and is board certified in internal medicine.</p>","image":{"available_sizes":[[[72,88],"assets/images/resized/0011/7600/117600v1-max-150x150.jpg"],[[72,88],"assets/images/resized/0011/7600/117600v1-max-250x250.jpg"],[[72,88],"assets/images/resized/0011/7600/117600v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"M.D. and Ph.D.","subject":"","institution":" Johns Hopkins Medical School","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Chief Executive Officer","firm":{"name":"Karyopharm Therapeutics","permalink":"karyopharm-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[150,34],"assets/images/resized/0010/8626/108626v1-max-150x150.png"],[[250,57],"assets/images/resized/0010/8626/108626v1-max-250x250.png"],[[338,78],"assets/images/resized/0010/8626/108626v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}